How does a high TC/HDL ratio affect heart disease risk?

The TC/HDL ratio compares total cholesterol to protective HDL cholesterol, with higher ratios indicating increased cardiovascular risk. A ratio above 5.0 significantly elevates heart disease risk, while optimal ratios below 3.5 suggest better cardiovascular health.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the TC/HDL Ratio

The total cholesterol to HDL cholesterol ratio (TC/HDL) is a powerful predictor of cardiovascular disease risk that provides more insight than looking at cholesterol numbers in isolation. This ratio compares your total cholesterol level to your high-density lipoprotein (HDL) cholesterol, often called 'good' cholesterol.

To calculate your TC/HDL ratio, simply divide your total cholesterol by your HDL cholesterol. For example, if your total cholesterol is 200 mg/dL and your HDL is 50 mg/dL, your ratio would be 4.0. This single number can tell you more about your heart disease risk than total cholesterol alone.

HDL cholesterol acts as a cardiovascular protector by removing excess cholesterol from your arteries and transporting it to your liver for disposal. When your HDL levels are low relative to your total cholesterol, this protective mechanism becomes less effective, allowing cholesterol to accumulate in your arterial walls and form plaques that can lead to heart attacks and strokes.

TC/HDL Ratio Risk Categories

Risk categories based on American Heart Association guidelines and cardiovascular outcome studies.
TC/HDL RatioRisk LevelInterpretationRecommended Action
Below 3.5< 3.5OptimalExcellent cardiovascular healthMaintain healthy lifestyle
3.5-5.03.5-5.0AcceptableAverage riskConsider lifestyle improvements
5.1-6.05.1-6.0Borderline HighIncreased riskImplement lifestyle changes, monitor closely
Above 6.0> 6.0High RiskSignificantly elevated riskAggressive lifestyle changes, consider medication

Risk categories based on American Heart Association guidelines and cardiovascular outcome studies.

What Is Considered a High TC/HDL Ratio?

Understanding where your TC/HDL ratio falls on the risk spectrum is crucial for assessing your cardiovascular health. Medical professionals use specific cutoff points to categorize risk levels and guide treatment decisions.

The American Heart Association considers a TC/HDL ratio above 5.0 to be a significant risk factor for heart disease. However, many cardiologists now recommend aiming for even lower ratios, particularly for individuals with other risk factors such as diabetes, hypertension, or a family history of heart disease.

Gender differences also play a role in interpreting these ratios. Women typically have higher HDL levels than men, which often results in more favorable ratios. However, after menopause, women's HDL levels may decrease, potentially worsening their TC/HDL ratio and increasing cardiovascular risk.

How High TC/HDL Ratios Increase Heart Disease Risk

A high TC/HDL ratio accelerates the development of atherosclerosis, the buildup of fatty deposits in your arteries. When your ratio is elevated, it indicates an imbalance between cholesterol delivery to your tissues and its removal, creating conditions that promote plaque formation.

This imbalance triggers a cascade of harmful processes in your blood vessels. Excess cholesterol particles, particularly low-density lipoprotein (LDL) cholesterol, penetrate the arterial walls where they become oxidized. This oxidation attracts immune cells that attempt to clear the cholesterol but instead become foam cells, forming the foundation of arterial plaques.

As plaques grow, they narrow your arteries and reduce blood flow to vital organs. More dangerously, these plaques can rupture, triggering blood clots that completely block blood flow. When this occurs in coronary arteries, it causes a heart attack; in brain arteries, it leads to a stroke. Studies show that for every 1.0 increase in the TC/HDL ratio, cardiovascular risk increases by approximately 20-30%.

The Role of Inflammation

High TC/HDL ratios often coincide with increased inflammation throughout the body. This inflammatory state further damages blood vessel walls and accelerates plaque formation. HDL cholesterol possesses anti-inflammatory properties, so when HDL levels are low relative to total cholesterol, this protective effect diminishes.

Impact on Blood Vessel Function

Beyond plaque formation, unfavorable TC/HDL ratios impair the normal function of your blood vessels. Healthy arteries can dilate and constrict as needed to regulate blood flow. However, when the TC/HDL ratio is high, this flexibility decreases, a condition called endothelial dysfunction. This dysfunction represents an early stage of cardiovascular disease and can occur even before significant plaque buildup.

Factors That Influence Your TC/HDL Ratio

Multiple factors contribute to your TC/HDL ratio, some within your control and others determined by genetics. Understanding these influences helps you identify which aspects of your health you can modify to improve your cardiovascular risk profile.

Lifestyle Factors

Diet plays a crucial role in determining your cholesterol levels and ratio. Consuming trans fats and excessive saturated fats raises total cholesterol while lowering HDL, creating a double negative impact on your ratio. Conversely, incorporating healthy fats from sources like olive oil, nuts, and fatty fish can improve your ratio by raising HDL levels.

Physical activity is one of the most effective ways to improve your TC/HDL ratio. Regular aerobic exercise can increase HDL cholesterol by 5-10% while simultaneously lowering total cholesterol. Even moderate activities like brisk walking for 30 minutes daily can produce meaningful improvements in your ratio over time.

Smoking significantly worsens the TC/HDL ratio by lowering HDL cholesterol and damaging blood vessels. Quitting smoking can increase HDL levels by up to 10% within just a few months, substantially improving your ratio and overall cardiovascular health.

Medical Conditions

Several medical conditions can adversely affect your TC/HDL ratio. Type 2 diabetes often leads to low HDL levels and elevated triglycerides, creating an atherogenic lipid profile. Metabolic syndrome, characterized by abdominal obesity, insulin resistance, and abnormal lipid levels, typically presents with unfavorable TC/HDL ratios.

Thyroid disorders, particularly hypothyroidism, can elevate total cholesterol levels and worsen your ratio. If you're experiencing unexplained changes in your cholesterol levels or struggling to improve your ratio despite lifestyle modifications, comprehensive testing can help identify underlying conditions.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Monitoring Your TC/HDL Ratio

Regular monitoring of your cholesterol levels and TC/HDL ratio is essential for maintaining cardiovascular health. The American Heart Association recommends that adults have their cholesterol checked every 4-6 years, starting at age 20. However, if you have risk factors or a family history of heart disease, more frequent testing may be necessary.

A standard lipid panel measures total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. From these values, your TC/HDL ratio can be easily calculated. However, advanced lipid testing can provide even more detailed information about your cardiovascular risk, including particle sizes and counts, which offer additional insights beyond the basic ratio.

When interpreting your results, remember that cholesterol levels can fluctuate based on recent meals, stress, illness, and other factors. For the most accurate assessment, tests should be performed after a 9-12 hour fast, and abnormal results should be confirmed with repeat testing before making significant treatment decisions.

Strategies to Improve Your TC/HDL Ratio

Improving your TC/HDL ratio requires a comprehensive approach that addresses both sides of the equation: lowering total cholesterol while raising HDL levels. The most effective strategies combine dietary modifications, increased physical activity, and when necessary, medical interventions.

Dietary Approaches

Adopting a Mediterranean-style diet rich in olive oil, nuts, fish, and vegetables has been shown to improve TC/HDL ratios significantly. This dietary pattern emphasizes healthy fats that raise HDL while limiting processed foods and refined carbohydrates that can worsen your lipid profile.

Specific foods that can help improve your ratio include fatty fish rich in omega-3 fatty acids, soluble fiber from oats and legumes, and plant sterols found in nuts and seeds. Limiting alcohol to moderate amounts (one drink per day for women, two for men) may also help raise HDL levels, though excessive alcohol consumption can have the opposite effect.

Exercise and Weight Management

Regular physical activity is one of the most powerful tools for improving your TC/HDL ratio. Aim for at least 150 minutes of moderate-intensity aerobic exercise per week, combined with strength training exercises twice weekly. High-intensity interval training (HIIT) has shown particular promise for raising HDL levels.

Weight loss, particularly reduction of abdominal fat, can significantly improve your ratio. Even modest weight loss of 5-10% of body weight can raise HDL levels and lower total cholesterol. The key is sustainable, gradual weight loss through balanced nutrition and regular physical activity rather than extreme dieting.

When to Consider Medical Treatment

While lifestyle modifications form the foundation of cholesterol management, some individuals may require medication to achieve optimal TC/HDL ratios. The decision to start medication depends on multiple factors, including your overall cardiovascular risk, the severity of your lipid abnormalities, and your response to lifestyle changes.

Statins remain the first-line medication for improving cholesterol profiles and reducing cardiovascular risk. These drugs primarily lower LDL cholesterol and total cholesterol, with modest effects on raising HDL. For individuals who cannot tolerate statins or need additional HDL improvement, other medications like fibrates or niacin may be considered, though their use has become less common due to mixed clinical trial results.

Regular monitoring is essential when taking cholesterol medications to ensure effectiveness and detect any side effects. If you're on cholesterol-lowering therapy, having your lipid levels checked every 3-6 months allows for appropriate dose adjustments and helps track your progress toward cardiovascular health goals.

The Bottom Line on TC/HDL Ratios and Heart Health

Your TC/HDL ratio provides valuable insight into your cardiovascular disease risk, offering a more complete picture than total cholesterol alone. While a ratio above 5.0 significantly increases your risk of heart disease, aiming for a ratio below 3.5 provides optimal protection against cardiovascular events.

The good news is that this ratio is highly modifiable through lifestyle changes. By adopting a heart-healthy diet, engaging in regular physical activity, maintaining a healthy weight, and avoiding smoking, most people can achieve meaningful improvements in their TC/HDL ratio. These changes not only improve your cholesterol profile but also provide widespread benefits for overall health and longevity.

Remember that improving your TC/HDL ratio is a gradual process that requires consistency and patience. Work with your healthcare provider to establish realistic goals, monitor your progress, and adjust your approach as needed. With dedication to heart-healthy habits and appropriate medical management when necessary, you can significantly reduce your cardiovascular risk and enjoy better health for years to come.

References

  1. Millán, J., Pintó, X., Muñoz, A., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Calling, S., Johansson, S. E., Wolff, M., et al. (2021). Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden. BMC Cardiovascular Disorders, 21(1), 163.[PubMed][DOI]
  3. Arsenault, B. J., Rana, J. S., Stroes, E. S., et al. (2009). Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology, 55(1), 35-41.[PubMed][DOI]
  4. Lemieux, I., Lamarche, B., Couillard, C., et al. (2001). Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Archives of Internal Medicine, 161(22), 2685-2692.[PubMed][DOI]
  5. Eliasson, B., Cederholm, J., Eeg-Olofsson, K., et al. (2014). Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register. Diabetes Care, 37(9), 2433-2441.[PubMed][DOI]
  6. Wang, T. D., Chen, W. J., Chien, K. L., et al. (2001). Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. American Journal of Cardiology, 88(7), 737-743.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my TC/HDL ratio at home?

You can test your TC/HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including total cholesterol, HDL, LDL, and triglycerides, allowing you to calculate your TC/HDL ratio and track it over time.

What is the optimal TC/HDL ratio for heart health?

The optimal TC/HDL ratio is below 3.5, which indicates excellent cardiovascular health. Ratios between 3.5-5.0 are considered acceptable, while ratios above 5.0 significantly increase heart disease risk. Women typically have slightly lower ratios than men due to higher HDL levels.

How quickly can I improve my TC/HDL ratio?

With consistent lifestyle changes, you can see improvements in your TC/HDL ratio within 6-12 weeks. Regular exercise can increase HDL by 5-10% in this timeframe, while dietary changes can lower total cholesterol. However, achieving optimal ratios may take several months of sustained effort.

Is the TC/HDL ratio more important than LDL cholesterol?

Both measurements provide valuable information about cardiovascular risk. The TC/HDL ratio offers a broader view of your cholesterol balance, while LDL cholesterol specifically measures the 'bad' cholesterol that forms plaques. Many doctors now consider multiple lipid markers, including both values, for comprehensive risk assessment.

Can genetics affect my TC/HDL ratio?

Yes, genetics play a significant role in determining your cholesterol levels and TC/HDL ratio. Some people inherit conditions like familial hypercholesterolemia that cause very high cholesterol, while others may have genetically low HDL levels. However, lifestyle modifications can still improve your ratio regardless of genetic predisposition.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details